Clinical recommendations for the use of recombinant human erythropoietin in patients with hepatitis C virus being treated with ribavirin

Today, combination antiviral therapy with pegylated interferon-alpha and ribavirin (RBV) allows many patients infected with hepatitis C virus (HCV) to achieve a sustained virological response, which is equivalent to cure. Data also support the clinical benefit of combination antiviral therapy in pat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sherman, Morris, Cohen, Lawrence, Anne Cooper, Mary, Elkashab, Magdy, Feinman, Victor, Fletcher, David, Girgrah, Nigel, Heathcote, Jenny, Levstik, Mark, McNaull, William B, Wong, David, Wong, Florence, Yim, Colina
Formato: Artigo
Lenguaje:Inglês
Publicado: Pulsus Group Inc 2006
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2659916/
https://ncbi.nlm.nih.gov/pubmed/16858501
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares